News | Coronavirus (COVID-19) | May 21, 2020

Extends access of AI software that supports chest imaging, including CT and X-ray, to U.S. radiologists at over 7,000 healthcare facilities

Extends access of AI software that supports chest imaging, including CT and X-ray, to U.S. radiologists at over 7,000 healthcare facilities

May 21, 2020 — RADLogics announced that its AI-powered medical imaging applications designed to assist in the detection and quantification of findings associated with COVID-19 will now be available on the Nuance AI Marketplace. The Nuance AI Marketplace is the first and largest portal with one-stop access to a wide range of AI diagnostic models from within the industry’s most widely used radiology reporting platform.

Following the announcement of global deployments of RADLogics’ AI-powered devices, the availability of RADLogics’ applications on the Nuance AI Marketplace include patient triage and disease extent measurements, using imaging findings on computed tomography (CT) and X-ray scans. Access to these applications will help meet the growing demand in the U.S. for these solutions that have the capacity to process 1 million CT and 10 million X-rays studies per day through the RADLogics’ cloud-based platform.

RADLogics’ AI-powered software includes algorithms that not only detect abnormalities on chest CTs and X-rays, but also provide automatic triage alerts to the radiologist to help ensure potential findings are reviewed in a timely matter. In addition, the AI-Powered devices provide quantitative analysis of the CT and X-ray images for patients with suspected COVID-19 disease including a score that can help monitor findings over time. In response to the COVID-19 pandemic, RADLogics has dedicated the company’s resources to modify, adapt, and deploy its algorithms to detect lung abnormalities that are compatible with COVID-19 in appropriate clinical settings.

The Nuance AI Marketplace functions like an app store dedicated to radiology. It gives algorithm developers consolidated, at-scale access to users of Nuance PowerScribe™, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 7,000 connected healthcare facilities. Radiologists can discover, test, and use AI models from within their familiar PowerScribe reporting and worklist workflows to increase reporting efficiency and quality, and to help care teams improve performance and reduce healthcare costs. A built-in feedback channel lets users share real-world results with developers for AI model refinement and post-market surveillance. Hospital systems benefit with simplified purchasing and metrics showing model usage, costs, and performance.

“We are committed to meet the growing demand for our AI-Powered medical imaging analysis solutions during the pandemic by making our applications available to U.S. clinicians and radiology teams through the revolutionary Nuance AI Marketplace,” said Moshe Becker, CEO and Co-Founder of RADLogics. “We are dedicated to supporting the fight against COVID-19, and Nuance’s cloud-based marketplace will facilitate the deployment of our applications to support healthcare systems and providers throughout the U.S. as they continue to treat symptomatic patients.”

In accordance with recent FDA guidance for imaging systems and software to address the COVID-19 public health emergency, RADLogics is committed to making its CT and X-ray solutions available to hospitals and healthcare systems throughout the U.S. for patient triage and management. Designed for easy integration and installation both on-premise and via the cloud – RADLogics’ algorithms are supported by the company’s patented workflow software platform that enables rapid deployment at multiple hospitals, and seamless integration with existing workflows.

For more information: www.radlogics.com


Related Content

News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Cybersecurity

March 23, 2026 —Sacumen has launched ConnectX, a unified AI platform that gives cybersecurity product companies full ...

Time March 25, 2026
arrow
News | Pediatric Imaging

March 17, 2026 – OXOS Medical recently announced that its MC2 portable X-ray system is now cleared for pediatric imaging ...

Time March 23, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 18, 2026 — GE HealthCare and Springbok Analytics have entered a development agreement that will aim to leverage ...

Time March 18, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
Subscribe Now